Joohyuk Sohn Selected Research

Aspartate Aminotransferases (Aspartate Transaminase)

1/2021

A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joohyuk Sohn Research Topics

Disease

85	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2010
29	Neoplasms (Cancer) 05/2024 - 01/2010
16	Disease Progression 03/2024 - 01/2019
14	Neutropenia 01/2024 - 12/2013
12	Neoplasm Metastasis (Metastasis) 06/2021 - 12/2013
5	Triple Negative Breast Neoplasms 01/2023 - 01/2014
5	Nausea 07/2020 - 09/2017
4	Diarrhea 06/2023 - 09/2017
3	Pathologic Complete Response 01/2023 - 01/2010
3	Febrile Neutropenia 08/2020 - 03/2016
2	Melanoma (Melanoma, Malignant) 04/2024 - 01/2020
2	Anemia 01/2024 - 11/2023
2	Exanthema (Rash) 06/2023 - 01/2021
2	Pneumonia (Pneumonitis) 01/2022 - 10/2020
2	Vomiting 07/2020 - 01/2020
2	Carcinoma (Carcinomatosis) 01/2020 - 01/2016
2	Fatigue 01/2020 - 09/2017
2	Alopecia (Baldness) 04/2019 - 06/2017
2	Circulating Neoplastic Cells 01/2017 - 04/2016
1	Thrombocytopenia (Thrombopenia) 01/2024
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Hypokalemia 01/2021
1	Ovarian Epithelial Carcinoma 01/2021
1	Atrial Fibrillation 01/2021
1	Hyperglycemia 01/2021

Drug/Important Bio-Agent (IBA)

36	Hormones (Hormone)IBA 12/2023 - 12/2013
12	Fulvestrant (Faslodex)FDA Link 03/2024 - 09/2017
10	abemaciclibIBA 01/2023 - 09/2017
9	human ERBB2 proteinIBA 12/2023 - 11/2017
8	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2012
7	ErbB Receptors (EGF Receptor)IBA 10/2023 - 11/2018
7	Trastuzumab (Herceptin)FDA Link 10/2022 - 01/2012
6	Estrogen ReceptorsIBA 03/2024 - 01/2017
6	palbociclibIBA 01/2024 - 12/2019
6	Cyclin-Dependent Kinase 4IBA 12/2023 - 09/2017
6	AnthracyclinesIBA 11/2023 - 01/2010
6	taxaneIBA 04/2023 - 01/2010
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 01/2012
6	Tamoxifen FDA LinkGeneric 04/2021 - 01/2018
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2020 - 12/2013
5	Aromatase InhibitorsIBA 03/2024 - 11/2017
5	Gonadotropin-Releasing Hormone (GnRH)FDA Link 03/2024 - 10/2018
5	Messenger RNA (mRNA)IBA 11/2023 - 01/2017
5	Letrozole (Femara)FDA LinkGeneric 10/2023 - 01/2018
4	eribulin FDA Link 12/2023 - 04/2017
4	ribociclibIBA 03/2022 - 01/2018
4	Everolimus FDA Link 05/2021 - 11/2019
4	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2019 - 12/2013
3	ParaffinIBA 01/2018 - 01/2012
3	Epidermal Growth Factor (EGF)IBA 01/2016 - 01/2012
2	Phenobarbital (Luminal)FDA Link 04/2024 - 01/2023
2	giredestrantIBA 03/2024 - 11/2023
2	Vinorelbine (Navelbine)FDA LinkGeneric 11/2023 - 12/2019
2	Taxoids (Taxanes)IBA 11/2023 - 04/2023
2	Circulating Tumor DNAIBA 01/2023 - 01/2021
2	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 01/2021
2	Biosimilar PharmaceuticalsIBA 10/2022 - 01/2021
2	trastuzumab deruxtecanIBA 01/2022 - 01/2020
2	Leuprolide (Lupron)FDA LinkGeneric 05/2021 - 01/2021
2	Alanine Transaminase (SGPT)IBA 01/2021 - 01/2021
2	PlatinumIBA 01/2021 - 01/2020
2	Goserelin (Zoladex)FDA Link 01/2021 - 11/2018
2	HM781-36BIBA 12/2020 - 01/2019
2	Monoclonal AntibodiesIBA 01/2020 - 01/2020
2	Immunoglobulin G (IgG)IBA 01/2020 - 01/2012
2	Lapatinib (GW572016)FDA Link 12/2019 - 10/2019
2	Gemcitabine FDA Link 11/2019 - 01/2019
2	Cyclin DIBA 01/2019 - 01/2019
2	Docetaxel (Taxotere)FDA Link 03/2016 - 12/2013
2	Formaldehyde (Formol)FDA Link 01/2015 - 01/2012
1	efineptakin alfaIBA 05/2024
1	Proteins (Proteins, Gene)FDA Link 04/2024
1	EnzymesIBA 01/2024
1	NivolumabIBA 12/2023
1	Pemetrexed (MTA)FDA Link 11/2023
1	Estrogen Receptor AntagonistsIBA 11/2023
1	2- (N- phenethyl- N- propyl)amino- 5- hydroxytetralinIBA 10/2023
1	capivasertibIBA 06/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2023
1	pipoxolan (BR 18)IBA 10/2022
1	talazoparibIBA 10/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 06/2021
1	AlpelisibIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	CT-P6IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	avelumabIBA 01/2021
1	NVP-BKM120IBA 01/2021
1	130-nm albumin-bound paclitaxelIBA 10/2020
1	LigandsIBA 10/2020

Therapy/Procedure

39	Therapeutics 03/2024 - 12/2013
27	Drug Therapy (Chemotherapy) 03/2024 - 12/2013
9	Neoadjuvant Therapy 01/2023 - 01/2010
5	Adjuvant Chemotherapy 01/2023 - 03/2016
2	Aftercare (After-Treatment) 06/2023 - 01/2018
2	Radiotherapy 01/2018 - 09/2017
1	Immunotherapy 05/2024
1	Drug Tapering 01/2021